Revatis is a prominent Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) that specializes in the production of muscle-derived Mesenchymal Stem/Stroma Cells. With a focus on Good Manufacturing Practice (GMP) manufacturing, Revatis supports research and development projects and clinical trials specifically within veterinary medicine. The company seeks to leverage its expertise to contribute to advancements in cell and gene therapy.

Services include:
– Cell and Gene Therapy
– Research & Development
– Clinical Trial Materials
– GMP Manufacturing of Muscle-Derived Stem Cells

Revatis is committed to delivering high-quality services that meet the stringent demands of the pharmaceutical industry. Their dedication to innovation and regulatory compliance positions them as a leader in the field. For more information, please visit revatis.com.